Inhaled corticosteroids for stable chronic obstructive pulmonary disease
IA Yang, MS Clarke, EHA Sim… - Cochrane Database of …, 2012 - cochranelibrary.com
Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much controversy. Major international guidelines …
disease (COPD) has been the subject of much controversy. Major international guidelines …
Advances in the treatment of Parkinson's disease
Parkinson's disease (PD) affects one in every 100 persons above the age of 65 years,
making it the second most common neurodegenerative disease after Alzheimer's disease …
making it the second most common neurodegenerative disease after Alzheimer's disease …
Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases
Both communicable and non-communicable chronic respiratory conditions have accorded
for suffering of millions of people of all ages and stated to be leading cause of death …
for suffering of millions of people of all ages and stated to be leading cause of death …
Risk of adverse reactions associated with inhaled corticosteroids for chronic obstructive pulmonary disease: A meta-analysis
C Lu, X Mao - Medicine, 2024 - journals.lww.com
Background: In the majority of current therapeutic regimens for chronic obstructive
pulmonary disease (COPD), bronchodilators are coupled with inhaled corticosteroids (ICS) …
pulmonary disease (COPD), bronchodilators are coupled with inhaled corticosteroids (ICS) …
Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis
MT Halpern, JK Schmier, MD Van Kerkhove… - Annals of allergy …, 2004 - Elsevier
BACKGROUND: The impact of long-term inhaled corticosteroid (ICS) therapy on bone
mineral density (BMD) is poorly understood. OBJECTIVE: To evaluate the impact of long …
mineral density (BMD) is poorly understood. OBJECTIVE: To evaluate the impact of long …
慢性阻塞性肺疾病治疗进展
李国平 - 实用医院临床杂志, 2007 - cqvip.com
慢性阻塞性肺疾病治疗进展-[维普官方网站]-www.cqvip.com-维普网 我的维普 购物车 充值 客服
首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 会议平台 | 学术机构 您的 …
首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 会议平台 | 学术机构 您的 …
The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease
CB Johannes, GA Schneider, TJ Dube, TD Alfredson… - Chest, 2005 - Elsevier
Objective To examine nonvertebral fracture risk in relation to inhaled corticosteroid (ICS)
exposure among adults with respiratory disease. Design and patients Nested case-control …
exposure among adults with respiratory disease. Design and patients Nested case-control …
Formoterol: a review of its use in chronic obstructive pulmonary disease
SM Cheer, LJ Scott - American Journal of Respiratory Medicine, 2002 - Springer
Abstract Inhaled formoterol is a long-acting selective β 2-adrenoceptor agonist, with an
onset of action of 5 minutes postdose and a bronchodilator effect that lasts for at least 12 …
onset of action of 5 minutes postdose and a bronchodilator effect that lasts for at least 12 …
Is there an association between inhaled corticosteroids and bone density in postmenopausal women?
S Elmståhl, H Ekström, H Galvard, O Johnell… - Journal of allergy and …, 2003 - Elsevier
Background: During the last decades, there has been increased concern about the
association between oral corticosteroid (OC) therapy and osteoporosis. Objective: The …
association between oral corticosteroid (OC) therapy and osteoporosis. Objective: The …
Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease
IA Yang, OR Ferry, MS Clarke… - Cochrane Database …, 2023 - cochranelibrary.com
Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much uncertainty. COPD clinical guidelines …
disease (COPD) has been the subject of much uncertainty. COPD clinical guidelines …